Trial Profile
Clinical efficacy of 0.15% Unoprostone on geographic atrophy after the treatment of wet AMD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2014
Price :
$35
*
At a glance
- Drugs Unoprostone (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 14 Apr 2014 New trial record